LTRN / Lantern Pharma Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

랜턴 파마 주식회사
US ˙ NasdaqCM ˙ US51654W1018

발행주식수 11,208,938 shares
내부자 지분5,593,455 shares
내부자 주주49.90 %
전체 내부자14
내부자 센티멘트 점수

내부자 센티멘트 점수를 통해서 내부자들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

이는 내부자의 누적도가 가장 높은 기업을 식별하는 정교하고 복합적인 지수를 분석하는 계량 모델의 결과 값입니다. 스코어링 모델은 이전 90일 동안 매수한 "내부자의 순 숫자", "매수한 주식의 총합", "내부자가 소유한 주식의 총합"의 조합을 사용합니다. 점수는 0에서 100 사이이며, 점수가 높을수록 피어(Peer: 동종업계 경쟁기업)에 대한 누적도가 높다는 것을 나타내며, 평균은 50입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

내부 경영진 센티멘트 점수

내부 경영진 센티멘트 점수를 통해서 내부 경영진들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

내부 거래의 정의에 따라 내부 경영진(기업 임원)도 내부자이지만, 다른 내부자(10% 주주 및 이사회 구성원)들과는 달리 내부 경영진은 매일 회사에서 근무하며, 거래 시에 자신의 자금을 사용합니다. (많은 경우에 10% 주주 및 이사회 구성원은 다른 사람의 자금을 관리하는 자금 관리자입니다.) 따라서 내부 경영진(기업 임원: Officer)의 내부 거래는 훨씬 더 중요하며 올바른 분석이 필요합니다.

내부자 센티멘트 점수와 마찬가지로 임원 감정 점수는 가장 높은 수준의 임원 축적을 가진 기업을 식별하는 정교하고 복합적인 지수 퀀트(Multi-factor quantitative) 모델의 결과입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

주요 내부자 지표

이 수치는 해당 기업이 다양한 내부자 지표에 따라 어떻게 순위를 매겨지는 지를 설명합니다. 백분위 순위는 이 기업이 미국 시장의 다른 기업들과 어떻게 비교되는지 보여줍니다. 순위가 높을수록 더 나은 상황에 있다는 것을 의미합니다.

예를 들어, 일반적으로 내부자의 매입은 긍정적인 지표라고 간주되어지기 때문에, 내부자의 매입(내부자의 매각, 역시도)가 적은 기업보다 내부자의 매입이 많은 기업은 순위가 높을 것입니다.

내부자의 순 매입(순위)

2 ( )
181 out of 10948

내부자의 순 매입(Net Number of Insiders Buying)는 내부자 매수의 총 수에서 지난 90일 동안의 내부자 매도의 총 수를 뺀 값입니다. 여기에 백분위 순위가 표시됩니다(범위: 0~100%).

내부자가 매입한 플로트 비율 (순위)

1.116% ( )
106 out of 10786

"내부자가 매입한 플로트 비율(Percent of Float Bought by Insiders)"은 내부자가 매입한 주식의 총 수에서 내부자가 매도한 주식의 총 수를 뺀 값을 전체 플로트로 나눈 값에 100을 곱한 값입니다. * ((내부자가 매입한 주식의 총 수 - 내부자가 매도한 주식의 총 수) ÷ 전체 플로트) x 100

내부자 트레이딩 차트

Lantern Pharma Inc. 내부자의 매매 거래는 아래 차트에 나와 있습니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다.

내부자의 명단 및 이익 지표

아래 표는 공개된 내부자의 목록이며, SEC에 공개된 제출 문서에서 자동으로 생성됩니다. "이름", "가장 최근의 직급", "이사, 임원 또는 10% 주주"에 대한 지정 외에도 최근에 공개된 보유 주식에 대한 정보를 보여줍니다. 또한 가능한 경우 내부자의 과거 거래 실적도 확인 가능합니다. 과거 거래 실적은 내부자가 실제 "공개 시장"(Open market) 매입 거래를 수행한 실적을 가중 평균한 값입니다. 이 계산 방법에 대한 자세한 내용은 유튜브 웨비나 를 참조하시면 됩니다.

See our leaderboard of most profitable insider traders.

내부자 평균 이익률 (%) 소유
지분
주식
분할
Arunkumar Asaithambi 10% Owner - [10%] 883,920 883,920
Biological Mimetics Inc 10% Owner - [10%] 2,088,000 2,088,000
BIOS Fund I QP, LP 10% Owner - [10%] 329,904 114,272
Bhatia Kishor G. 17,400
내부자 평균 이익률 (%) 소유
지분
주식
분할
Vijay Chandru 3,200
Fletcher Aaron G.L. 10% Owner - [10%] 114,272 114,272
Green Park & Golf Ventures II, LLC 10% Owner - [10%] 131,697 131,697
D Jeffrey Keyser Director - [D] 94,303 94,303
Kreis Leslie W. 10% Owner - [10%] 144,719 144,719
내부자 평균 이익률 (%) 소유
지분
주식
분할
Margrave David R. 26,100
Franklyn G Prendergast 3,200
Panna Sharma 76,628
Lee Troy Schalop Director - [D] 48,544 48,544
Silberstein David S. Director, 10% Owner - [D] [10%] 2,088,000 2,088,000

Report errors via our new Insider Auditing Tool

내부자의 매입 내역 추적: 단기 이익 분석

이 섹션에서는 LTRN / Lantern Pharma Inc.에서 계획되지 않은 "공개 시장"(Open market)의 내부자가 매입한 모든 상품의 수익성을 분석합니다. 이 분석을 통해서 내부자가 비정상적인 수익을 지속적으로 창출하는지 파악하는 데 도움이 되며, 이러한 분석은 수행해볼 가치가 있습니다. 이 분석은 개별 거래 후 1년 동안 수행한 것이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 "공개 시장"(Open market)에서의 매입을 보여줍니다.

거래일 내부자 보고된
지분
보고된
가격
조정된
지분
조정된
가격
가격 기준 최고까지
일수
최고에서
가격
최고
이익 ($)
최고 수익률 (%)
2026-05-12 Schalop Lee Troy 48,544 2.0600 48,544 2.0600 100,001 23 3.7900 83,982 83.98
2026-05-12 KEYSER D JEFFREY 48,544 2.0600 48,544 2.0600 100,001
2020-06-11 KEYSER D JEFFREY 10,000 15.0000 10,000 15.0000 150,000

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

LTRN / Lantern Pharma Inc. Insider Trades
내부자 매매의 실적: 단기 손실 분석

이 섹선에서는 LTRN / Lantern Pharma Inc.에서 이루어진 "공개 시장(Open market)"에서의 모든 계획되지 않은 내부자 매매의 단기 손실 회피(Short-term loss avoidance)를 분석합니다. 일관된 손실 회피 패턴을 통해서 향후 매매 거래가 가격 하락을 초래할 수도 있음을 예상할 수 있습니다. 이 분석은 각 각 매매 거래 후 1년 동안의 자료이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장에서의 매매를 보여줍니다.

거래일 내부자 보고된
지분
보고된
가격
조정된
지분
조정된
가격
가격 기준 최저까지
일수
최저에서
가격
회피된
최대 손실($)
회피된
최대 손실율(%)
2025-06-13 Kreis Leslie W. 7,206 3.0900 7,206 3.0900 22,267 287 1.1200 -14,195 -63.75
2025-06-13 Kreis Leslie W. 12,319 3.0900 12,319 3.0900 38,066
2025-06-13 Kreis Leslie W. 1,903 3.0900 1,903 3.0900 5,880
2025-06-13 Kreis Leslie W. 14,218 3.0900 14,218 3.0900 43,934
2025-06-13 Kreis Leslie W. 4,354 3.0900 4,354 3.0900 13,454
2025-06-12 Kreis Leslie W. 10,925 3.3800 10,925 3.3800 36,926
2025-06-12 Kreis Leslie W. 18,678 3.3800 18,678 3.3800 63,132
2025-06-12 Kreis Leslie W. 2,886 3.3800 2,886 3.3800 9,755
2025-06-12 Kreis Leslie W. 21,557 3.3800 21,557 3.3800 72,863

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

LTRN / Lantern Pharma Inc. Insider Trades
거래 내역

전체 거래 내역을 보려면 링크 아이콘을 클릭하세요. 10b5-1 자동 거래 계획의 일부로 보고된 거래는 10b-5 열에 X 표시가 나타납니다.

보고일 거래일 양식 내부자 티커 증권 소유권 코드 10b5-1 직접 행사
가격
단위
가격
단위
변동
가치
변동 (단위: 1,000)
잔여
옵션
잔여
주식
2026-05-14 2026-05-12 4 KEYSER D JEFFREY LTRN Common stock, $0.001 par value P - Purchase D 2.0600 48,544 100 94,303
2026-05-14 2026-05-12 4 Schalop Lee Troy LTRN Common stock, $0.001 par value P - Purchase D 2.0600 48,544 100 48,544
2025-06-13 2025-06-13 4 Fletcher Aaron G.L. by Bios Fund II, LP LTRN Common Stock S - Sale I 3.0900 -4,354 -13 114,272
2025-06-13 2025-06-13 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.0900 -14,218 -44 373,178
2025-06-13 2025-06-13 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.0900 -1,903 -6 49,957
2025-06-13 2025-06-13 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.0900 -12,319 -38 323,335
2025-06-13 2025-06-13 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.0900 -7,206 -22 189,117
2025-06-13 2025-06-13 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3.0900 -4,354 -13 114,272
2025-06-13 2025-06-13 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.0900 -14,218 -44 373,178
2025-06-13 2025-06-13 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.0900 -1,903 -6 49,957
2025-06-13 2025-06-13 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.0900 -12,319 -38 323,335
2025-06-13 2025-06-13 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.0900 -7,206 -22 189,117
2025-06-13 2025-06-12 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 3.3800 -6,601 -22 118,626
2025-06-13 2025-06-12 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.3800 -21,557 -73 387,396
2025-06-13 2025-06-12 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.3800 -2,886 -10 51,860
2025-06-13 2025-06-12 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.3800 -18,678 -63 335,654
2025-06-13 2025-06-12 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.3800 -10,925 -37 196,323
2025-06-13 2025-06-11 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 3.4000 -103 -0 125,227
2025-06-13 2025-06-11 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.4000 -338 -1 408,953
2025-06-13 2025-06-11 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.4000 -45 -0 54,746
2025-06-13 2025-06-11 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.4000 -293 -1 354,332
2025-06-13 2025-06-11 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.4000 -171 -1 207,248
2025-06-13 2025-06-10 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 3.4000 -2 -0 125,330
2025-06-13 2025-06-10 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.4000 -5 -0 409,291
2025-06-13 2025-06-10 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.4000 -5 -0 409,291
2025-06-13 2025-06-10 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.4000 -1 -0 54,791
2025-06-13 2025-06-10 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.4000 -3 -0 207,419
2025-06-13 2025-06-12 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3.3800 -6,601 -22 118,626
2025-06-13 2025-06-12 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.3800 -21,557 -73 387,396
2025-06-13 2025-06-12 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.3800 -2,886 -10 51,860
2025-06-13 2025-06-12 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.3800 -18,678 -63 335,654
2025-06-13 2025-06-12 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.3800 -10,925 -37 196,323
2025-06-13 2025-06-11 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3.4000 -103 -0 125,227
2025-06-13 2025-06-11 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.4000 -338 -1 408,953
2025-06-13 2025-06-11 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.4000 -45 -0 54,746
2025-06-13 2025-06-11 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.4000 -293 -1 354,332
2025-06-13 2025-06-11 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.4000 -171 -1 207,248
2025-06-13 2025-06-10 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3.4000 -2 -0 125,330
2025-06-13 2025-06-10 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.4000 -5 -0 409,291
2025-06-13 2025-06-10 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.4000 -5 -0 409,291
2025-06-13 2025-06-10 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.4000 -1 -0 54,791
2025-06-13 2025-06-10 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.4000 -3 -0 207,419
2025-05-29 2025-05-29 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 3.0300 -2,199 -7 125,332
2025-05-29 2025-05-29 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.0300 -7,180 -22 409,296
2025-05-29 2025-05-29 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.0300 -961 -3 54,792
2025-05-29 2025-05-29 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.0300 -6,221 -19 354,630
2025-05-29 2025-05-29 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.0300 -3,639 -11 207,422
2025-05-29 2025-05-28 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 2.8700 -1,632 -5 127,531
2025-05-29 2025-05-28 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 2.8700 -5,332 -15 416,476
2025-05-29 2025-05-28 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 2.8700 -714 -2 55,753
2025-05-29 2025-05-28 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 2.8700 -4,620 -13 360,851
2025-05-29 2025-05-28 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 2.8700 -2,702 -8 211,061
2025-05-29 2025-05-27 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 3.0500 -2,290 -7 129,163
2025-05-29 2025-05-27 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.0500 -7,478 -23 421,808
2025-05-29 2025-05-27 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.0500 -1,000 -3 56,467
2025-05-29 2025-05-27 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.0500 -6,479 -20 365,471
2025-05-29 2025-05-27 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.0500 -3,790 -12 213,763
2025-05-29 2025-05-29 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3.0300 -2,199 -7 125,332
2025-05-29 2025-05-29 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.0300 -7,180 -22 409,296
2025-05-29 2025-05-29 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.0300 -961 -3 54,792
2025-05-29 2025-05-29 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.0300 -6,221 -19 354,630
2025-05-29 2025-05-29 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.0300 -3,639 -11 207,422
2025-05-29 2025-05-28 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 2.8700 -1,632 -5 127,531
2025-05-29 2025-05-28 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 2.8700 -5,332 -15 416,476
2025-05-29 2025-05-28 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 2.8700 -714 -2 55,753
2025-05-29 2025-05-28 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 2.8700 -4,620 -13 360,851
2025-05-29 2025-05-28 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 2.8700 -2,702 -8 211,061
2025-05-29 2025-05-27 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 3.0500 -2,290 -7 129,163
2025-05-29 2025-05-27 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 3.0500 -7,478 -23 421,808
2025-05-29 2025-05-27 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 3.0500 -1,000 -3 56,467
2025-05-29 2025-05-27 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.0500 -6,479 -20 365,471
2025-05-29 2025-05-27 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.0500 -3,790 -12 213,763
2024-07-26 2024-07-24 4 KEYSER D JEFFREY LTRN Common stock X - Other D 3.1300 3,832 12 0
2024-05-28 2024-05-24 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 6.3300 -4,253 -27 131,453
2024-05-28 2024-05-24 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 6.3300 -13,888 -88 429,286
2024-05-28 2024-05-24 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 6.3300 -1,859 -12 57,467
2024-05-28 2024-05-23 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 6.2500 -2,126 -13 135,706
2024-05-28 2024-05-23 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 6.2500 -6,944 -43 443,174
2024-05-28 2024-05-23 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 6.2500 -930 -6 59,326
2024-05-28 2024-05-24 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 6.3300 -4,253 -27 131,453
2024-05-28 2024-05-24 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 6.3300 -13,888 -88 429,286
2024-05-28 2024-05-24 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 6.3300 -1,859 -12 57,467
2024-05-28 2024-05-23 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 6.2500 -2,126 -13 135,706
2024-05-28 2024-05-23 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 6.2500 -6,944 -43 443,174
2024-05-28 2024-05-23 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 6.2500 -930 -6 59,326
2024-02-29 2024-02-29 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 4.8700 -4,185 -20 137,832
2024-02-29 2024-02-29 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4.8700 -13,686 -67 450,118
2024-02-29 2024-02-29 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4.8700 -1,832 -9 60,256
2024-02-29 2024-02-28 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 4.8500 -15,780 -77 142,017
2024-02-29 2024-02-28 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4.8500 -51,608 -250 463,804
2024-02-29 2024-02-28 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4.8500 -6,909 -34 62,088
2024-02-29 2024-02-27 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 4.4000 -10,620 -47 157,797
2024-02-29 2024-02-27 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4.4000 -34,731 -153 515,412
2024-02-29 2024-02-27 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4.4000 -4,649 -20 68,997
2024-02-29 2024-02-29 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 4.8700 -4,185 -20 137,832
2024-02-29 2024-02-29 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4.8700 -13,686 -67 450,118
2024-02-29 2024-02-29 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4.8700 -1,832 -9 60,256
2024-02-29 2024-02-28 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 4.8500 -15,780 -77 142,017
2024-02-29 2024-02-28 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4.8500 -51,608 -250 463,804
2024-02-29 2024-02-28 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4.8500 -6,909 -34 62,088
2024-02-29 2024-02-27 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 4.4000 -10,620 -47 157,797
2024-02-29 2024-02-27 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4.4000 -34,731 -153 515,412
2024-02-29 2024-02-27 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4.4000 -4,649 -20 68,997
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 4.2000 -12,521 -53 168,417
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock X - Other I 3.1300 16,801 53 180,938
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4.2000 -40,893 -172 550,143
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock X - Other I 3.1300 54,873 172 591,036
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4.2000 -5,475 -23 73,646
2024-01-19 2024-01-17 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock X - Other I 3.1300 7,347 23 79,121
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 4.2000 -12,521 -53 168,417
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock X - Other I 3.1300 16,801 53 180,938
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4.2000 -40,893 -172 550,143
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock X - Other I 3.1300 54,873 172 591,036
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4.2000 -5,475 -23 73,646
2024-01-19 2024-01-17 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock X - Other I 3.1300 7,347 23 79,121
2023-12-01 2023-11-29 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.4400 -91,708 -315 371,950
2023-12-01 2023-11-29 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.4400 -53,640 -185 217,553
2023-12-01 2023-11-29 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 3.4400 -91,708 -315 371,950
2023-12-01 2023-11-29 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 3.4400 -53,640 -185 217,553
2022-11-09 2022-11-08 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock S - Sale I 4.4000 -40,586 -179 164,137
2022-11-09 2022-11-08 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4.4000 -132,575 -583 536,163
2022-11-09 2022-11-08 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4.4000 -17,748 -78 71,774
2022-11-09 2022-11-08 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock S - Sale I 4.4000 -100,380 -442 463,658
2022-11-09 2022-11-08 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 4.4000 -58,711 -258 271,193
2022-11-09 2022-11-08 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock S - Sale I 4.4000 -40,586 -179 164,137
2022-11-09 2022-11-08 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock S - Sale I 4.4000 -132,575 -583 536,163
2022-11-09 2022-11-08 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock S - Sale I 4.4000 -17,748 -78 71,774
2022-11-09 2022-11-08 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock S - Sale I 4.4000 -100,380 -442 463,658
2022-11-09 2022-11-08 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock S - Sale I 4.4000 -58,711 -258 271,193
2022-09-07 2022-09-02 4 Fletcher Aaron G.L. By BP Directors, LP LTRN Common Stock S - Sale I 5.2000 -1,275 -7 26,093
2022-09-07 2022-09-02 4 Fletcher Aaron G.L. By BP Directors, LP LTRN Common Stock X - Other I 1.0300 6,438 7 27,328
2022-09-07 2022-09-02 4 Fletcher Aaron G.L. By BP Directors, LP LTRN Common Stock S - Sale I 5.2000 -5,170 -27 20,930
2022-09-07 2022-09-02 4 Fletcher Aaron G.L. By BP Directors, LP LTRN Common Stock X - Other I 1.0300 26,100 27 26,100
2022-09-07 2022-09-02 4 Kreis Leslie W. By BP Directors,LP LTRN Common Stock S - Sale I 5.2000 -1,275 -7 26,093
2022-09-07 2022-09-02 4 Kreis Leslie W. By BP Directors,LP LTRN Common Stock X - Other I 1.0300 6,438 7 27,328
2022-09-07 2022-09-02 4 Kreis Leslie W. By BP Directors,LP LTRN Common Stock S - Sale I 5.2000 -5,170 -27 20,930
2022-09-07 2022-09-02 4 Kreis Leslie W. By BP Directors,LP LTRN Common Stock X - Other I 1.0300 26,100 27 26,100
2022-03-21 2022-03-17 4 Kreis Leslie W. Bios Fund I QP, LP LTRN Series A Warrants X - Other I -35,347 0
2022-03-21 2022-03-17 4 Kreis Leslie W. Bios Fund I, LP LTRN Series A Warrants X - Other I -60,432 0
2022-03-21 2022-03-17 4 Kreis Leslie W. Bios Fund I QP, LP LTRN Common Stock X - Other I 110,636.1100 35,347 3,910,655 329,904
2022-03-21 2022-03-17 4 Kreis Leslie W. Bios Fund I, LP LTRN Common Stock X - Other I 189,152.1600 60,432 11,430,843 564,038
2021-11-08 2021-11-04 4 Kreis Leslie W. By BP Directors, LP LTRN Stock Option A - Award I 10.32 3,200 3,200
2021-11-08 2021-11-04 4 Silberstein David S. LTRN Stock Option (Right to Buy) A - Award D 10.32 3,200 3,200
2021-11-08 2021-11-04 4 Chandru Vijay LTRN Stock Option (Right to Buy) A - Award D 10.32 3,200 3,200
2021-11-08 2021-11-04 4 PRENDERGAST FRANKLYN G LTRN Stock Option (Right to Buy) A - Award D 10.32 3,200 3,200
2021-11-08 2021-11-04 4 KEYSER D JEFFREY LTRN Stock Option (Right to Buy) A - Award D 10.32 3,200 3,200
2021-11-02 2021-10-29 4 Margrave David R. LTRN Stock Option (Right to Buy) A - Award D 10.21 26,100 26,100
2021-11-02 2021-10-29 4 Bhatia Kishor G. LTRN Stock Option (Right to Buy) A - Award D 10.21 17,400 17,400
2020-06-17 2020-06-16 4 Green Park & Golf Ventures II, LLC LTRN Series A Preferred Stock, par value $0.01 C - Conversion I -75,688 0
2020-06-17 2020-06-15 4 Green Park & Golf Ventures II, LLC LTRN Series A Preferred Stock, par value $0.01 C - Conversion I -168,164 0
2020-06-17 2020-06-15 4 Green Park & Golf Ventures II, LLC LTRN Series A Preferred Stock, par value $0.01 C - Conversion I -23,871 0
2020-06-17 2020-06-15 4 Green Park & Golf Ventures II, LLC LTRN Common Stock, par value $0.0001 C - Conversion I 131,697 131,697
2020-06-17 2020-06-15 4 Green Park & Golf Ventures II, LLC LTRN Common Stock, par value $0.0001 C - Conversion I 292,605 292,605
2020-06-17 2020-06-15 4 Green Park & Golf Ventures II, LLC LTRN Common Stock, par value $0.0001 C - Conversion I 41,535 211,291
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By affiliate LTRN Stock Options J - Other I 15.00 9,135 9,135
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Series A Preferred Stock C - Conversion I -35,181 0
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Series A Preferred Stock C - Conversion I -262,806 0
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Series A Preferred Stock C - Conversion I -80,454 0
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Series A Preferred Stock C - Conversion I -169,286 0
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Series A Preferred Stock C - Conversion I -289,429 0
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II NT, LP LTRN Common Stock C - Conversion I 61,214 89,522
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II QP, LP LTRN Common Stock C - Conversion I 457,282 668,738
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund II, LP LTRN Common Stock C - Conversion I 139,989 204,723
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund I QP, LP LTRN Common Stock C - Conversion I 294,557 294,557
2020-06-16 2020-06-15 4 Fletcher Aaron G.L. By Bios Fund I, LP LTRN Common Stock C - Conversion I 503,606 503,606
2020-06-16 2020-06-15 4 Kreis Leslie W. LTRN Stock Options A - Award D 15.00 9,135 9,135
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Series A Preferred Stock C - Conversion I -35,181 0
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Series A Preferred Stock C - Conversion I -262,806 0
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II, LP LTRN Series A Preferred Stock C - Conversion I -80,454 0
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Series A Preferred Stock C - Conversion I -169,286 0
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund I, LP LTRN Series A Preferred Stock C - Conversion I -289,429 0
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II NT, LP LTRN Common Stock C - Conversion I 61,214 89,522
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II QP, LP LTRN Common Stock C - Conversion I 457,282 668,738
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund II, LP LTRN Common Stock C - Conversion I 139,989 204,723
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund I QP, LP LTRN Common Stock C - Conversion I 294,557 294,557
2020-06-16 2020-06-15 4 Kreis Leslie W. By Bios Fund I, LP LTRN Common Stock C - Conversion I 503,606 503,606
2020-06-15 2020-06-15 4 PRENDERGAST FRANKLYN G LTRN Stock Option A - Award D 15.00 9,135 9,135
2020-06-15 2020-06-15 4 Bhatia Kishor G. LTRN Stock Option A - Award D 15.00 52,200 52,200
2020-06-15 2020-06-15 4 SHARMA PANNA LTRN Stock Option A - Award D 15.00 76,628 76,628
2020-06-15 2020-06-15 4 Chandru Vijay LTRN Stock Option A - Award D 15.00 9,135 9,135
2020-06-15 2020-06-15 4 Margrave David R. LTRN Stock Option A - Award D 15.00 78,300 78,300
2020-06-15 2020-06-15 4 Silberstein David S. LTRN Stock Option A - Award D 15.00 9,135 9,135
2020-06-15 2020-06-11 4 KEYSER D JEFFREY LTRN Common Stock P - Purchase D 15.0000 10,000 150 10,000
2020-06-15 2020-06-15 4 KEYSER D JEFFREY LTRN Stock Option A - Award D 15.00 9,135 9,135
2020-06-15 2020-06-15 4 KEYSER D JEFFREY LTRN Series A Preferred Stock C - Conversion D -18,349 0
2020-06-15 2020-06-15 4 KEYSER D JEFFREY LTRN Common Stock C - Conversion D 31,927 41,927
2020-06-10 3 Asaithambi Arunkumar LTRN Common Stock D 883,920
2020-06-10 3 Asaithambi Arunkumar LTRN Common Stock D 883,920
2020-06-10 3 Asaithambi Arunkumar LTRN Common Stock D 883,920
2020-06-10 3 BIOLOGICAL MIMETICS INC LTRN Common Stock D 2,088,000
2020-06-10 3 BIOLOGICAL MIMETICS INC LTRN Common Stock D 2,088,000
2020-06-10 3 BIOLOGICAL MIMETICS INC LTRN Common Stock D 2,088,000
2020-06-10 3 Silberstein David S. See Explanation of Responses. LTRN Common Stock I 2,088,000
2020-06-10 3 Silberstein David S. See Explanation of Responses. LTRN Common Stock I 2,088,000
2020-06-10 3 Silberstein David S. See Explanation of Responses. LTRN Common Stock I 2,088,000
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339,512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339,512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339,512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339,512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339,512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339,512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339,512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339,512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339,512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339,512
2020-06-10 3 Soderstrom Carl D LTRN Common Stock, par value $0.0001 I 339,512
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BP Directors, LP By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BP Directors, LP By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BP Directors, LP By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II NT, LP LTRN Common Stock I 332,806
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II QP, LP LTRN Common Stock I 515,954
2020-06-10 3 BIOS Advisors GP, LLC By Bios Fund II, LP LTRN Common Stock I 369,232
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista